Integrin αX activators encompass a diverse group of chemicals that either directly engage with the integrin to modulate its activation state or indirectly influence its activity through various signaling pathways. These activators include natural compounds like mangiferin and epigallocatechin gallate, synthetic peptides like cilengitide, and a range of small-molecule inhibitors that target specific enzymes or signaling pathways. The primary mode of action of these chemicals varies from direct interaction with the integrin, altering its conformation and affinity for ligands, to the modulation of intracellular pathways that control the integrin's activation state and clustering on the cell surface. The indirect activators such as forskolin, LY294002, and SB203580, operate by manipulating cellular signaling cascades like the cAMP pathway, PI3K/AKT pathway, and the p38 MAPK pathway, respectively. These pathways are crucial in regulating integrin inside-out signaling, which controls the affinity and avidity of integrins for their ligands. The modulation of these pathways can result in altered integrin activation, influencing cell adhesion, migration, and other integrin-mediated processes. Forskolin, for example, elevates intracellular cAMP levels, which can lead to changes in integrin activation states. LY294002 and SB203580, by inhibiting specific kinases, affect downstream signaling events that can indirectly influence the activation state of Integrin αX.
The direct activators, on the other hand, such as cilengitide, interact with the integrin molecule itself. Cilengitide is a notable example as it binds to the integrin, affecting its conformation and potentially its interaction with natural ligands. This category also includes compounds like genistein and Tyrphostin B42, which, despite being classified as kinase inhibitors, can have direct effects on integrin activation due to the complex nature of integrin signaling and cross-talk with other cellular pathways. These compounds highlight the intricate balance of integrin activation, where external modulation by small molecules can have significant impacts on the functional state of these critical cell adhesion receptors. Integrin αX activators represent a multifaceted chemical class that influences integrin function through various mechanisms, reflecting the complexity and significance of integrin-mediated cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mangiferin | 4773-96-0 | sc-491041 | 10 mg | $140.00 | ||
Mangiferin is a natural xanthone known to enhance the activation of Integrins, including Integrin αX. It modulates cellular adhesion and migration processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a diterpene, activates adenylate cyclase, increasing cAMP levels, which can indirectly influence Integrin αX activation through intracellular signaling. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Cilengitide is a cyclic peptide that targets integrins, including αX. It can modulate the activation state of these integrins, impacting their binding and signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone, indirectly affects Integrin αX activation through its role as a tyrosine kinase inhibitor, influencing cellular adhesion mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin, found in green tea, can modulate Integrin signaling, potentially altering the activation state of Integrin αX. | ||||||
TAPI-2 | 187034-31-7 | sc-205851 sc-205851A | 1 mg 5 mg | $286.00 $1019.00 | 15 | |
TAPI-2 is an inhibitor of ADAM17, a protease that cleaves membrane proteins. Its inhibition can affect Integrin activation, including αX. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002, can influence Integrin activation by modulating downstream signaling pathways, potentially affecting Integrin αX. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor can indirectly affect Integrin αX activation through its role in cellular signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, PD98059, may indirectly influence Integrin αX activation through the ERK/MAPK pathway. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42, a JAK2 inhibitor, can influence the activation of Integrins, including αX, by modulating cytokine signaling pathways. | ||||||